Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer

Oncogene

Volumn 33, Issue 19, 2014, Pages 2513-2519

  Palla, A R ^a   Piazzolla, D ^a   Abad, M ^a   Li, H ^a   Dominguez, O ^a   Schonthaler, H B ^b   Wagner, E F ^b   Serrano, M ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b BBVA University Institute for Economic and Social Analysis University of Alcalá   (Spain)

Author keywords

cancer; NANOG; NANOGP8; pluripotency; reprogramming

Indexed keywords

DOXYCYCLINE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR NANOGP8; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL LINE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; EMBRYONIC STEM CELLS; GENE KNOCKDOWN TECHNIQUES; HOMEODOMAIN PROTEINS; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84900412898     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.196     Document Type: Article

References (35)

1. Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development 2009; 136: 2311-2322.
2. Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O et al. Nanog is the gateway to the pluripotent ground state. Cell 2009; 138: 722-737.
3. Booth HA, Holland PW. Eleven daughters of NANOG. Genomics 2004; 84: 229-238.
4. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113: 643-655.
5. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113: 631-642.
6. Wang SH, Tsai MS, Chiang MF, Li H. A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells. Gene Expr Patterns 2003; 3: 99-103.
7. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
8. Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009; 462: 595-601.
9. Theunissen TW, Costa Y, Radzisheuskaya A, van Oosten AL, Lavial F, Pain B et al. Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain. Development 2011; 138: 4853-4865.
10. Eberle I, Pless B, Braun M, Dingermann T, Marschalek R. Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells. Nucleic Acids Res 2010; 38: 5384-5395.
11. Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I, Ruiz i et al. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 2010; 29: 2659-2674.
12. Chang DF, Tsai SC, Wang XC, Xia P, Senadheera D, Lutzko C. Molecular characterization of the human NANOG protein. Stem Cells 2009; 27: 812-821.
13. Pan G, Pei D. The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus. J Biol Chem 2005; 280: 1401-1407.
14. Do HJ, Lee WY, Lim HY, Oh JH, Kim DK, Kim JH et al. Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells. J Cell Biochem 2009; 106: 1079-1089.
15. Ambady S, Malcuit C, Kashpur O, Kole D, Holmes WF, Hedblom E et al. Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. Int J Dev Biol 2010; 54: 1743-1754.
16. Ishiguro T, Sato A, Ohata H, Sakai H, Nakagama H, Okamoto K. Differential expression of nanog1 and nanogp8 in colon cancer cells. Biochem Biophys Res Commun 2012; 418: 199-204.
17. Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009; 27: 993-1005.
18. Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011; 30: 3833-3845.
19. Zhang J, Wang X, Li M, Han J, Chen B, Wang B et al. NANOGP8 is a retrogene expressed in cancers. FEBS J 2006; 273: 1723-1730.
20. Zhang J, Espinoza LA, Kinders RJ, Lawrence SM, Pfister TD, Zhou M et al. NANOG modulates stemness in human colorectal cancer. Oncogene 2013; 32: 4397-4405.
21. Uchino K, Hirano G, Hirahashi M, Isobe T, Shirakawa T, Kusaba H et al. Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp Cell Res 2012; 318: 1799-1807.
22. Zhang J, Wang X, Chen B, Xiao Z, Li W, Lu Y et al. The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development. Oncol Lett 2010; 1: 457-463.
23. Suva ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science 2013; 339: 1567-1570.
24. Kim JS, Kim J, Kim BS, Chung HY, Lee YY, Park CS et al. Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog. Exp Mol Med 2005; 37: 601-607.
25. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J et al. The ground state of embryonic stem cell self-renewal. Nature 2008; 453: 519-523.
26. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 2008; 6: e253.
27. Moretto-Zita M, Jin H, Shen Z, Zhao T, Briggs SP, Xu Y. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci USA 2010; 107: 13312-13317.
28. Ramakrishna S, Suresh B, Lim KH, Cha BH, Lee SH, Kim KS et al. PEST motif sequence regulating human NANOG for proteasomal degradation. Stem Cells Dev 2011; 20: 1511-1519.
29. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, Flavell RA et al. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2008; 2: 595-601.
30. Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 2010; 115: 2769-2776.
31. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 2008; 105: 2883-2888.
32. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA 2009; 106: 157-162.
33. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005; 121: 465-477.
34. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
35. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.